Bridging Integrator 2 (BIN2) (Middle Region) Peptid
BIN2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle BIN2 Produkte
- BIN2 (Bridging Integrator 2 (BIN2))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- DYEEKLADQA VRTMEIYVAQ FSEIKERIAK RGRKLVDYDS ARHHLEAVQN
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- BIN2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BIN2 (Bridging Integrator 2 (BIN2))
- Hintergrund
-
May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.
Alias Symbols: BRAP-1
Protein Size: 475 - Gen-ID
- 51411
- NCBI Accession
- NM_001290007, NP_001276936
-
Sie sind hier:
